Cargando…

Drug Policy Research & Pharmacoeconomics

Detalles Bibliográficos
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2008
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086147/ https://www.ncbi.nlm.nih.gov/pubmed/21593973

Ejemplares similares

Pharmacoeconomics; an Appropriate Tool for Policy Makers or Just a New Field of Research in Iran?
por: Davari, Majid
Publicado: (2012)

Pharmacoeconomic Evaluations: Guidelines for Drug Purchasers
por: Langley, Paul C., et al.
Publicado: (2020)

The importance of publishing research protocols for pharmacoeconomic studies
por: Dane, Aniek, et al.
Publicado: (2023)

Essentials of pharmacoeconomics
por: Rascati, Karen L.
Publicado: (2014)

Principles of pharmacoeconomics /
Publicado: (1996)

On the Use of Markov Models in Pharmacoeconomics: Pros and Cons and Implications for Policy Makers
por: Carta, Andrea, et al.
Publicado: (2020)

Quality of pharmacoeconomic research in China: A systematic review
por: Ma, Huifen, et al.
Publicado: (2016)

1715 Oseltamivir use in an Influenza Outbreak: Linking Pharmacology to Pharmacoeconomics
por: Chaiyakunapruk, Nathorn, et al.
Publicado: (2014)

Pharmacoeconomics Aspects of Antiepileptic Drugs in Pediatric Patients with Epilepsy
por: Kopciuch, Dorota, et al.
Publicado: (2022)

Clinical Observation and Pharmacoeconomic Evaluations of Original Research Drug and Generic Drug Bortezomib in the Treatment of Multiple Myeloma
por: Liang, Yongchao, et al.
Publicado: (2022)

80. Pharmacoeconomic Analysis Comparing the Empiric Utilization of Cefepime Versus Piperacillin/tazobactam
por: Olmack, Kelsey, et al.
Publicado: (2020)

Pharmacoeconomics for migraine and headache researchers: basic concepts, methods and terminology
por: Walley, Tom
Publicado: (2004)

Retracted: Clinical Observation and Pharmacoeconomic Evaluations of Original Research Drug and Generic Drug Bortezomib in the Treatment of Multiple Myeloma
por: Healthcare Engineering, Journal of
Publicado: (2023)

Incorporating Pharmacometrics into Pharmacoeconomic Models: Applications from Drug Development
por: Srinivasan, Meenakshi, et al.
Publicado: (2020)

Pharmacoeconomics in COPD: lessons for the future
por: Starkie, Helen J, et al.
Publicado: (2008)

Fluid management: the pharmacoeconomic dimension
por: Vincent, Jean-Louis
Publicado: (2000)

Development of pharmacoeconomics guidelines for India
por: Thomas, Dixon, et al.
Publicado: (2014)

Formulary Management Methods and Pharmacoeconomics
por: Curtiss, Frederic R.
Publicado: (2003)

Pharmacoeconomic Benefits of Antihypertensive Therapy
por: Gonzalez, Edgar R.
Publicado: (2007)

Need for pharmacoeconomic consideration of antiepileptic drugs monotherapy treatment in persons with epilepsy
por: Sarangi, Sudhir C., et al.
Publicado: (2020)

The pharmacoeconomics of the state-of-the-art drug treatments for asthma: a systematic review
por: Menzella, Francesco, et al.
Publicado: (2021)

739 Outcomes and pharmacoeconomic analysis of a home intravenous antibiotic infusion program in veterans
por: Ruh, Christine, et al.
Publicado: (2014)

It's Only a Pharmacoeconomic Model--Believe It or Not
por: Fairman, Kathleen A., et al.
Publicado: (2008)

Pharmacoeconomic considerations in the treatment of breast cancer
por: Pallis, Athanasios, et al.
Publicado: (2010)

Grand Challenges in Pharmacoeconomics and Health Outcomes
por: Dubois, Dominique J.
Publicado: (2010)

Pharmacoeconomics guidelines: The need of hour for India
por: Oberoi, Sukhvinder Singh, et al.
Publicado: (2014)

Pharmacoeconomic studies in Nepal: the need of the hour
por: Acharya, Mahip
Publicado: (2014)

Pharmacoeconomic evaluations in the treatment of actinic keratoses
por: Tolley, Keith, et al.
Publicado: (2017)

Systematic review of pharmacoeconomic models for schizophrenia
por: Zhou, Junwen, et al.
Publicado: (2018)

Pharmacoeconomics in Africa: needs, prospect and challenges
por: Ben-Ajepe, Temitope, et al.
Publicado: (2021)

CHEERS to 30 Years of PharmacoEconomics
por: Milne, Richard, et al.
Publicado: (2021)

Pharmacoeconomic Challenges in the Management of Diabetic Nephropathy
por: Rodby, Roger A.
Publicado: (2004)

Trends and frontiers of research on pharmacoeconomics from 2012–2021: a scientometric analysis
por: Liu, Yan, et al.
Publicado: (2022)

98. Clinical and Pharmacoeconomic Impact of Rapid Diagnostic Pneumonia Panel in Critically Ill Patients Admitted with Nosocomial Pneumonia
por: Kerr, Kathryn H, et al.
Publicado: (2020)

Improving the efficiency of cost-effectiveness analysis to inform policy decisions in the real world: lessons from the Pharmacoeconomics Research Unit at Cancer Care Ontario
por: Hoch, Jeffrey S
Publicado: (2014)

Policy Series: ESPO/ Social Research, Policy, and Practice Section Symposium: Connecting Aging Research to Policy: Insights and Strategies for Early-Career Researchers
por: Pendergrast, Claire, et al.
Publicado: (2020)

Pharmacoeconomic Modeling of Drug Therapies for Multiple Sclerosis - Are We Building Houses on Sand?
por: Curtiss, Frederic R.
Publicado: (2007)

The role of pharmacoeconomics in current Indian healthcare system
por: Ahmad, Akram, et al.
Publicado: (2013)

Pharmacoeconomic Education for Pharmacy Students in Bosnia and Herzegovina
por: Catić, Tarik, et al.
Publicado: (2013)

Pharmacoeconomic aspects of the treatment of pituitary gland tumours
por: Sowiński, Jerzy, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6di1v844bj725dj5p8ciq4ad13